Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 oct. 2023 09h05 HE | Source: Stereotaxis, Inc.

Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023

ST. LOUIS, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
04 oct. 2023 08h49 HE | Source: Stereotaxis, Inc.

Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation

ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
06 sept. 2023 08h56 HE | Source: Stereotaxis, Inc.

Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology

ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
30 août 2023 08h49 HE | Source: Stereotaxis, Inc.

Overland Park Regional Medical Center Becomes First U.S. Hospital with Two Stereotaxis Robotic Systems for Arrhythmia Treatment

ST. LOUIS, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
16 août 2023 08h40 HE | Source: Stereotaxis, Inc.

Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium

ST. LOUIS, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its...
10 août 2023 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Reports 2023 Second Quarter Financial Results

ST. LOUIS, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
18 juil. 2023 09h18 HE | Source: Stereotaxis, Inc.

Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients

ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first...
17 juil. 2023 06h00 HE | Source: Stereotaxis, Inc.

Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023

ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
15 juin 2023 16h10 HE | Source: Stereotaxis, Inc.

Stereotaxis to Initiate First-in-Human Trial to Support CE Mark Application of MAGiC Catheter

ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
25 mai 2023 08h56 HE | Source: Stereotaxis, Inc.

Stereotaxis to Participate in 20th Annual Craig-Hallum Institutional Investor Conference

ST. LOUIS, May 25, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...

Page précédente

Page suivante